Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01629459 · ClinicalTrials.gov registry record · NA

Resistance Exercise in Barth Syndrome

A NA study, sponsored by Washington University School of Medicine.

Completed
Registry status
NA
Development phase
12
Enrollment target

NCT01629459 is a NA study that has completed, run by Washington University School of Medicine. The registered enrollment target is 12 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01629459, a NA study, has completed, sponsored by Washington University School of Medicine.

COMPLETED
Registry status
NA
Development phase
12 participants
Enrollment target

Study Summary

Barth syndrome (BTHS) is a disorder that is characterized by heart failure, exercise intolerance and skeletal muscle weakness. Preliminary evidence demonstrates that endurance exercise training does not significantly improve exercise tolerance in BTHS. Because endurance exercise training targets a metabolic pathway that is adversely affected by BTHS, the investigators hypothesized that resistance training may improve exercise tolerance in BTHS because this type of training targets a different metabolic pathway than does endurance exercise. Therefore, the overall objective of the pilot/feasibility/proof-of-concept proposal is to collect preliminary data on the following hypothesis: Supervised resistance exercise training (3x/wk, 45min, 12 wks) will improve exercise tolerance, heart function, muscle strength and quality of life, and will be found safe in adolescents and young adults with BTHS.

Interventions

  • BEHAVIORAL Resistance exercise and protein supplementation

Trial Details

FieldValue
Enrollment Target 12 participants
Start Date 2012-06
Est. Completion 2019-06-30
Phase NA

What the Registry Record Tells You About NCT01629459

The ClinicalTrials.gov registry entry for NCT01629459 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Resistance exercise and protein supplementation is the first listed.

NCT01629459 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01629459 about?

NCT01629459 is a clinical study titled "Resistance Exercise in Barth Syndrome". Barth syndrome (BTHS) is a disorder that is characterized by heart failure, exercise intolerance and skeletal muscle weakness. Preliminary evidence demonstrates that endurance exercise training does not significantly improve exercise tolerance in BTHS. Because endurance exercise training targets a m...

What is the current status of trial NCT01629459?

This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2012-06. Estimated completion is 2019-06-30.

What interventions are being tested in trial NCT01629459?

The interventions under investigation include: Resistance exercise and protein supplementation (BEHAVIORAL).

Who is sponsoring clinical trial NCT01629459?

This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.